▶ 調査レポート

世界の血糖用自己モニタリング用穿刺器具市場2022-2028:調整式穿刺装置、非調整式穿刺装置

• 英文タイトル:Lancing Devices for Self-Monitoring of Blood Glucose Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが調査・発行した産業分析レポートです。世界の血糖用自己モニタリング用穿刺器具市場2022-2028:調整式穿刺装置、非調整式穿刺装置 / Lancing Devices for Self-Monitoring of Blood Glucose Market, Global Outlook and Forecast 2022-2028 / MR2211MG11530資料のイメージです。• レポートコード:MR2211MG11530
• 出版社/出版日:Market Monitor Global / 2022年11月
• レポート形態:英文、PDF、79ページ
• 納品方法:Eメール(納期:2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥481,000 (USD3,250)▷ お問い合わせ
  Enterprise User¥625,300 (USD4,225)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は次の情報を含め、血糖用自己モニタリング用穿刺器具のグローバル市場規模と予測を記載しています。・血糖用自己モニタリング用穿刺器具のグローバル市場:売上、2017年-2022年、2023年-2028年
・血糖用自己モニタリング用穿刺器具のグローバル市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

血糖用自己モニタリング用穿刺器具のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「調整式穿刺装置」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

血糖用自己モニタリング用穿刺器具のグローバル主要企業は、Roche、 Lifescan、 Abbott、 Ascensia、 B. Braun、 TERUMO、 Sinocare、 ARKRAY、 GMMC Group、 BIONIME、 LIANFA、 Lobeck Medical AGなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル(MMG)社は、血糖用自己モニタリング用穿刺器具のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の血糖用自己モニタリング用穿刺器具市場:タイプ別、2017年-2022年、2023年-2028年
世界の血糖用自己モニタリング用穿刺器具市場:タイプ別市場シェア、2021年
・調整式穿刺装置、非調整式穿刺装置

世界の血糖用自己モニタリング用穿刺器具市場:用途別、2017年-2022年、2023年-2028年
世界の血糖用自己モニタリング用穿刺器具市場:用途別市場シェア、2021年
・オンライン、オフライン

世界の血糖用自己モニタリング用穿刺器具市場:地域・国別、2017年-2022年、2023年-2028年
世界の血糖用自己モニタリング用穿刺器具市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における血糖用自己モニタリング用穿刺器具のグローバル売上、2017年-2022年
・主要企業における血糖用自己モニタリング用穿刺器具のグローバル売上シェア、2021年
・主要企業における血糖用自己モニタリング用穿刺器具のグローバル販売量、2017年-2022年
・主要企業における血糖用自己モニタリング用穿刺器具のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Roche、 Lifescan、 Abbott、 Ascensia、 B. Braun、 TERUMO、 Sinocare、 ARKRAY、 GMMC Group、 BIONIME、 LIANFA、 Lobeck Medical AG

*************************************************************

・調査・分析レポートの概要
血糖用自己モニタリング用穿刺器具市場の定義
市場セグメント
世界の血糖用自己モニタリング用穿刺器具市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の血糖用自己モニタリング用穿刺器具市場規模
世界の血糖用自己モニタリング用穿刺器具市場規模:2021年 VS 2028年
世界の血糖用自己モニタリング用穿刺器具市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの血糖用自己モニタリング用穿刺器具の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の血糖用自己モニタリング用穿刺器具製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:調整式穿刺装置、非調整式穿刺装置
血糖用自己モニタリング用穿刺器具のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:オンライン、オフライン
血糖用自己モニタリング用穿刺器具の用途別グローバル売上・予測

・地域別市場分析
地域別血糖用自己モニタリング用穿刺器具市場規模 2021年と2028年
地域別血糖用自己モニタリング用穿刺器具売上・予測
北米市場
- アメリカの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- カナダの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- メキシコの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
ヨーロッパ市場
- ドイツの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- フランスの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- イギリスの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- イタリアの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- ロシアの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
アジア市場
- 中国の血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- 日本の血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- 韓国の血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- 東南アジアの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- インドの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
南米市場
- ブラジルの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- アルゼンチンの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
中東・アフリカ市場
- トルコの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- イスラエルの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- サウジアラビアの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年
- UAEの血糖用自己モニタリング用穿刺器具市場規模2017年-2028年

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Roche、 Lifescan、 Abbott、 Ascensia、 B. Braun、 TERUMO、 Sinocare、 ARKRAY、 GMMC Group、 BIONIME、 LIANFA、 Lobeck Medical AG
...

Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
This report contains market size and forecasts of Lancing Devices for Self-Monitoring of Blood Glucose in global, including the following market information:
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Lancing Devices for Self-Monitoring of Blood Glucose companies in 2021 (%)
The global Lancing Devices for Self-Monitoring of Blood Glucose market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adjustable Lancing Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lancing Devices for Self-Monitoring of Blood Glucose include Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY and GMMC Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lancing Devices for Self-Monitoring of Blood Glucose manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lancing Devices for Self-Monitoring of Blood Glucose Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Segment Percentages, by Type, 2021 (%)
Adjustable Lancing Device
Non-adjustable Lancing Device
Global Lancing Devices for Self-Monitoring of Blood Glucose Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Segment Percentages, by Application, 2021 (%)
Online
Offline
Global Lancing Devices for Self-Monitoring of Blood Glucose Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lancing Devices for Self-Monitoring of Blood Glucose revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lancing Devices for Self-Monitoring of Blood Glucose revenues share in global market, 2021 (%)
Key companies Lancing Devices for Self-Monitoring of Blood Glucose sales in global market, 2017-2022 (Estimated), (Units)
Key companies Lancing Devices for Self-Monitoring of Blood Glucose sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Lancing Devices for Self-Monitoring of Blood Glucose Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lancing Devices for Self-Monitoring of Blood Glucose Overall Market Size
2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size: 2021 VS 2028
2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales: 2017-2028
3 Company Landscape
3.1 Top Lancing Devices for Self-Monitoring of Blood Glucose Players in Global Market
3.2 Top Global Lancing Devices for Self-Monitoring of Blood Glucose Companies Ranked by Revenue
3.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Companies
3.4 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Companies
3.5 Global Lancing Devices for Self-Monitoring of Blood Glucose Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Lancing Devices for Self-Monitoring of Blood Glucose Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Lancing Devices for Self-Monitoring of Blood Glucose Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lancing Devices for Self-Monitoring of Blood Glucose Players in Global Market
3.8.1 List of Global Tier 1 Lancing Devices for Self-Monitoring of Blood Glucose Companies
3.8.2 List of Global Tier 2 and Tier 3 Lancing Devices for Self-Monitoring of Blood Glucose Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size Markets, 2021 & 2028
4.1.2 Adjustable Lancing Device
4.1.3 Non-adjustable Lancing Device
4.2 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue & Forecasts
4.2.1 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2022
4.2.2 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2023-2028
4.2.3 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share, 2017-2028
4.3 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales & Forecasts
4.3.1 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2022
4.3.2 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2023-2028
4.3.3 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share, 2017-2028
4.4 By Type – Global Lancing Devices for Self-Monitoring of Blood Glucose Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2021 & 2028
5.1.2 Online
5.1.3 Offline
5.2 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue & Forecasts
5.2.1 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2022
5.2.2 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2023-2028
5.2.3 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share, 2017-2028
5.3 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales & Forecasts
5.3.1 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2022
5.3.2 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2023-2028
5.3.3 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share, 2017-2028
5.4 By Application – Global Lancing Devices for Self-Monitoring of Blood Glucose Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2021 & 2028
6.2 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue & Forecasts
6.2.1 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2022
6.2.2 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2023-2028
6.2.3 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share, 2017-2028
6.3 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales & Forecasts
6.3.1 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2022
6.3.2 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2023-2028
6.3.3 By Region – Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2028
6.4.2 By Country – North America Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2028
6.4.3 US Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.4.4 Canada Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.4.5 Mexico Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2028
6.5.2 By Country – Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2028
6.5.3 Germany Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5.4 France Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5.5 U.K. Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5.6 Italy Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5.7 Russia Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5.8 Nordic Countries Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.5.9 Benelux Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2028
6.6.2 By Region – Asia Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2028
6.6.3 China Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.6.4 Japan Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.6.5 South Korea Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.6.6 Southeast Asia Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.6.7 India Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2028
6.7.2 By Country – South America Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2028
6.7.3 Brazil Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.7.4 Argentina Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales, 2017-2028
6.8.3 Turkey Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.8.4 Israel Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.8.5 Saudi Arabia Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
6.8.6 UAE Lancing Devices for Self-Monitoring of Blood Glucose Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.1.4 Roche Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.1.5 Roche Key News
7.2 Lifescan
7.2.1 Lifescan Corporate Summary
7.2.2 Lifescan Business Overview
7.2.3 Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.2.4 Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.2.5 Lifescan Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.3.4 Abbott Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.3.5 Abbott Key News
7.4 Ascensia
7.4.1 Ascensia Corporate Summary
7.4.2 Ascensia Business Overview
7.4.3 Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.4.4 Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.4.5 Ascensia Key News
7.5 B. Braun
7.5.1 B. Braun Corporate Summary
7.5.2 B. Braun Business Overview
7.5.3 B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.5.4 B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.5.5 B. Braun Key News
7.6 TERUMO
7.6.1 TERUMO Corporate Summary
7.6.2 TERUMO Business Overview
7.6.3 TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.6.4 TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.6.5 TERUMO Key News
7.7 Sinocare
7.7.1 Sinocare Corporate Summary
7.7.2 Sinocare Business Overview
7.7.3 Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.7.4 Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.7.5 Sinocare Key News
7.8 ARKRAY
7.8.1 ARKRAY Corporate Summary
7.8.2 ARKRAY Business Overview
7.8.3 ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.8.4 ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.8.5 ARKRAY Key News
7.9 GMMC Group
7.9.1 GMMC Group Corporate Summary
7.9.2 GMMC Group Business Overview
7.9.3 GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.9.4 GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.9.5 GMMC Group Key News
7.10 BIONIME
7.10.1 BIONIME Corporate Summary
7.10.2 BIONIME Business Overview
7.10.3 BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.10.4 BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.10.5 BIONIME Key News
7.11 LIANFA
7.11.1 LIANFA Corporate Summary
7.11.2 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Business Overview
7.11.3 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.11.4 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.11.5 LIANFA Key News
7.12 Lobeck Medical AG
7.12.1 Lobeck Medical AG Corporate Summary
7.12.2 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Business Overview
7.12.3 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Major Product Offerings
7.12.4 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Sales and Revenue in Global (2017-2022)
7.12.5 Lobeck Medical AG Key News
8 Global Lancing Devices for Self-Monitoring of Blood Glucose Production Capacity, Analysis
8.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Production Capacity, 2017-2028
8.2 Lancing Devices for Self-Monitoring of Blood Glucose Production Capacity of Key Manufacturers in Global Market
8.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lancing Devices for Self-Monitoring of Blood Glucose Supply Chain Analysis
10.1 Lancing Devices for Self-Monitoring of Blood Glucose Industry Value Chain
10.2 Lancing Devices for Self-Monitoring of Blood Glucose Upstream Market
10.3 Lancing Devices for Self-Monitoring of Blood Glucose Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lancing Devices for Self-Monitoring of Blood Glucose Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer